A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency

被引：0

作者：

Afschin Gandjour

机构：

[1] Frankfurt School of Finance & Management,

来源：

BMC Health Services Research | / 20卷

关键词：

Cost-effectiveness; Drugs; Innovation; Pricing; I18;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 8 条

[1] A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency
Gandjour, Afschin
BMC HEALTH SERVICES RESEARCH, 2020, 20 (01)
[2] A PROPORTIONAL RULE FOR DETERMINING CEILING PRICES OF NEW INNOVATIVE DRUGS
Gandjour, A.
VALUE IN HEALTH, 2013, 16 (03) : A269 - A269
[3] Germany's decision rule for setting ceiling prices of drugs: A comparative analysis with other decision rules
Gandjour A.
Applied Health Economics and Health Policy, 2011, 9 (2) : 65 - 71
[4] The reimbursement decision speed for oncology new drugs in China and its determinant factors
Zhu, Xingyue
Chen, Yang
FRONTIERS IN PUBLIC HEALTH, 2023, 11
[5] COST-EFFECTIVE PHARMACEUTICAL CARE IN THE NETHERLANDS? A REVIEW OF THE PHARMACOECONOMICS AND ITS ROLE IN THE ASSESSMENT AND REIMBURSEMENT OF NEW DRUGS
Hoomans, T.
Roer, N. V. D.
Severens, J. L.
Delwel, G. O.
VALUE IN HEALTH, 2009, 12 (07) : A241 - A241
[6] HOW DO THE STRICTER PRICING REGULATIONS OF THE STATUTORY HEALTH INSURANCE FINANCIAL STABILIZATION ACT (GKV-FINSTG) AFFECT REIMBURSEMENT PRICES OF NEW DRUGS IN GERMANY?
Bot, D.
Leismann, J.
Beenk, K.
Ecker, T.
VALUE IN HEALTH, 2023, 26 (12) : S359 - S359
[7] New non-interactive form of the proportional-integral-derivative-acceleration (PIDA) controller and its explicit tuning rule
Jae Pil Heo
Sanghun Lim
Chang Gyu Im
Kyung Hwan Ryu
Su Whan Sung
Korean Journal of Chemical Engineering, 2023, 40 : 1277 - 1283
[8] New non-interactive form of the proportional-integral-derivative-acceleration (PIDA) controller and its explicit tuning rule
Heo, Jae Pil
Lim, Sanghun
Im, Chang Gyu
Ryu, Kyung Hwan
Sung, Su Whan
KOREAN JOURNAL OF CHEMICAL ENGINEERING, 2023, 40 (06) : 1277 - 1283

← 1 →